Combined androgen blockade for the treatment of metastatic cancer of the prostate

Urology. 1996 May;47(5):622-8. doi: 10.1016/s0090-4295(96)00002-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Male
  • Neoplasm Metastasis
  • Orchiectomy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Survival Rate

Substances

  • Androgen Antagonists